PDCO vs. HSIC, OMI, MCK, COR, CAH, EXEL, RDY, GMED, MEDP, and EHC
Should you be buying Patterson Companies stock or one of its competitors? The main competitors of Patterson Companies include Henry Schein (HSIC), Owens & Minor (OMI), McKesson (MCK), Cencora (COR), Cardinal Health (CAH), Exelixis (EXEL), Dr. Reddy's Laboratories (RDY), Globus Medical (GMED), Medpace (MEDP), and Encompass Health (EHC). These companies are all part of the "medical" sector.
Patterson Companies vs.
Henry Schein (NASDAQ:HSIC) and Patterson Companies (NASDAQ:PDCO) are both mid-cap medical companies, but which is the superior stock? We will compare the two businesses based on the strength of their institutional ownership, valuation, earnings, media sentiment, analyst recommendations, profitability, risk, community ranking and dividends.
96.6% of Henry Schein shares are held by institutional investors. Comparatively, 85.4% of Patterson Companies shares are held by institutional investors. 1.1% of Henry Schein shares are held by company insiders. Comparatively, 1.9% of Patterson Companies shares are held by company insiders. Strong institutional ownership is an indication that endowments, large money managers and hedge funds believe a stock is poised for long-term growth.
Henry Schein has a beta of 0.9, meaning that its share price is 10% less volatile than the S&P 500. Comparatively, Patterson Companies has a beta of 0.99, meaning that its share price is 1% less volatile than the S&P 500.
Henry Schein received 17 more outperform votes than Patterson Companies when rated by MarketBeat users. Likewise, 51.63% of users gave Henry Schein an outperform vote while only 50.42% of users gave Patterson Companies an outperform vote.
Henry Schein has higher revenue and earnings than Patterson Companies. Patterson Companies is trading at a lower price-to-earnings ratio than Henry Schein, indicating that it is currently the more affordable of the two stocks.
Henry Schein presently has a consensus price target of $81.10, indicating a potential upside of 12.64%. Patterson Companies has a consensus price target of $26.57, indicating a potential downside of 14.79%. Given Henry Schein's stronger consensus rating and higher probable upside, equities research analysts plainly believe Henry Schein is more favorable than Patterson Companies.
Henry Schein has a net margin of 2.51% compared to Patterson Companies' net margin of 2.37%. Patterson Companies' return on equity of 19.77% beat Henry Schein's return on equity.
In the previous week, Henry Schein had 14 more articles in the media than Patterson Companies. MarketBeat recorded 18 mentions for Henry Schein and 4 mentions for Patterson Companies. Patterson Companies' average media sentiment score of 1.29 beat Henry Schein's score of 0.85 indicating that Patterson Companies is being referred to more favorably in the news media.
Summary
Henry Schein beats Patterson Companies on 14 of the 19 factors compared between the two stocks.
Get Patterson Companies News Delivered to You Automatically
Sign up to receive the latest news and ratings for PDCO and its competitors with MarketBeat's FREE daily newsletter.
New MarketBeat Followers Over Time
This chart shows the number of new MarketBeat users adding {thisCompany.Symbol} and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period.
Skip ChartMedia Sentiment Over Time
This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.
Skip Chart
Patterson Companies Competitors List
Related Companies and Tools
This page (NASDAQ:PDCO) was last updated on 3/19/2025 by MarketBeat.com Staff